IMiD: Immunomodulatory Drug Lenalidomide (CC-5013; Revlimid) in the Treatment of Lymphoma: Insights into Clinical Use and Molecular Mechanisms

Overview of attention for article published in this source, January 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,592 followers.

RT @pashtoonkasi: 🆕📚 Book chapter- my master’s #research #thesis IMiD 💡 #immunotherapy @MayoClinicCIM @MayoCancerCare #ScholarAlerts https:…

Reply Repost Favourite

🆕📚 Book chapter- my master’s #research #thesis IMiD 💡 #immunotherapy @MayoClinicCIM @MayoCancerCare #ScholarAlerts https://t.co/5iDLmzQYo0

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.